Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines
by Murray, Sam et al
29th August 2025 •
comment
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
by Mariana O Diniz et al
21st May 2024 •
comment
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation
by Alex Sigal et al
22nd April 2024 •
comment